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Synthesis of Three-, Five-, and Six-Membered Heterocycles
Derived from New β-Amino-α-trifluoromethyl Alcohols
Abstract
Nucleophilic trifluoromethylation of α-iminoketones 2, derived from arylglyoxal, with Ruppert-Prakash
reagent (CF3SiMe3) offers a convenient access to the corresponding O-silylated
β-imino-α-trifluoromethyl alcohols. In a ‘one-pot' procedure, by treatment with NaBH4, these products
smoothly undergo reduction and desilylation yielding the expected β-amino-α-trifluoromethyl alcohols
4. The latter were used as convenient starting materials for the synthesis of diverse trifluoromethylated
heterocycles, including aziridines 5, 1,3-oxazolidines 8, 1,3-oxazolidin-2-ones 9,
1,3,2-oxazaphospholidine 2-oxides 10, 1,2,3-oxathiazolidine 2-oxides 11, and morpholine-2,3-diones
12. An optically active 5-trifluoromethyl-substituted 1,3-oxazolidin-2-one 9g was also obtained.
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Nucleophilic trifluoromethylation of -iminoketones 2, derived from arylglyoxal, with 
Ruppert-Prakash reagent (CF3SiMe3) offers a convenient access to the corresponding O-
silylated -imino--trifluoromethyl alcohols. In a ‘one-pot’ procedure, by treatment with 
NaBH4, these products smoothly undergo reduction and desilylation yielding the expected β-
amino--trifluoromethyl alcohols 4. The latter were used as convenient starting materials for 
the synthesis of diverse trifluoromethylated heterocycles, including aziridines 5, 1,3-
oxazolidines 8, 1,3-oxazolidin-2-ones 9, 1,3,2-oxazaphospholidine 2-oxides 10, 1,2,3-
oxathiazolidine 2-oxides 11, and morpholine-2,3-diones 12. An optically active 5-
trifluoromethyl-substituted 1,3-oxazolidin-2-one 9g was also obtained.  
 
 
Keywords. -Amino--trifluoromethyl alcohols; aziridines, 2-trifluoromethyl; 1,3-
oxazolidines, 5-trifluoromethyl; 1,3,2-oxazaphospholidines, 5-trifluoromethyl; 1,2,3-
oxathiazolidines, 5-trifluoromethyl; trifluoromethyl heterocycles 
3 
1. Introduction. – A series of papers published in the last two decades evidences the 
growing interest in the elaboration of new methods for the preparation of -amino--
trifluoromethyl alcohols in both chiral and achiral form [1]. In general, there are three main 
strategies applied. The first one is the Henry reaction of fluoral or hexafluoroacetone with 
nitroalkanes, followed by the reduction of the NO2 group. The second method is based on the 
ring opening of trifluoromethyloxiranes with primary or secondary amines. Finally, 
nucleophilic trifluoromethylation of -amino aldehydes or -amino ketones with 
trimethyl(trifluoromethyl)silane (Ruppert-Prakash reagent [2]) is probably the most frequently 
applied method [1]. In recent papers from our group, another approach was applied, and the 
chemoselective trifluoromethylation of the C=O group of -iminoketones 1 and 2 derived from 
camphorquinone and arylglyoxals, respectively, was followed by treatment with NaBH4 [3]. In 
the last case, a one-pot procedure leads simultaneously to desilylation and selective reduction 
of the C=N bond yielding the corresponding -amino--trifluoromethyl alcohols 4 (Scheme 1). 
On the other hand, -iminoketones of type 1, by treatment with NaBH4, undergo only 
desilylation, and the reduction of the C=N bond, leading to amino alcohols 3, was achieved 
only by using DIBAL-H for the final step of the procedure. 
 
Scheme 1 
 
In the case of amino alcohol 3 (R = Me), the reaction of the major diastereoisomer with 
phosgene yielded the desired 1,3-oxazolidin-2-one [3a]. This preliminary result prompted us to 
explore a series of other easily available -amino--trifluoromethyl alcohols 4 for the synthesis 
of trifluoromethylated heterocycles with diverse ring-size. 
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2. Results and Discussion. – In general, -amino alcohols of type 4 are crystalline and 
stable compounds, which can be stored for a long time without special precautions. In one of 
the studied cases, i.e., 4a (Ar = 4-NO2C6H4, R = t-Bu), the crystal-structure was established by 
X-ray crystallography (Fig. 1). 
 
Fig. 1. ORTEP-Plot [4] of the molecular structure of 4a (with 50% probability ellipsoids; 
arbitrary numbering of the atoms) 
 
The hydroxy group of 4a forms an intramolecular H-bond with the amine N-atom, and 
thereby creates a five-membered loop which can be described by a graph set motif [5] of S(5). 
The NH-group does not appear to form any significant H-bonds, although there might be a very 
weak intramolecular interaction with one of the F-atoms. 
The three-membered aziridines are heterocyclic compounds with fundamental 
importance in organic synthesis [6].
 
Special interest is focussed on aziridines, which contain 
fluorine atoms or perfluorinated alkyl groups. However, the limited availability of proper 
starting materials is reflected in a relatively low number of papers dealing with syntheses of 
fluorine-containing aziridines [7]. 
It is well known that -amino alcohols are convenient starting materials for the 
synthesis of aziridines via direct or multi-step cyclization [6a]. For this reason, trifluoromethyl-
substituted -amino alcohols were explored as convenient substrates for the preparation of 
aziridines with a new substitution pattern. First attempts were made following Gabriel’s 
method, which is based on the initial conversion of a -amino alcohol to the corresponding -
5 
halo amine and subsequent treatment with a base [8]. In the case of 4b (Ar = Ph, R =t-Bu), the 
attempted synthesis of the aziridine was unsuccessful
2
). 
A successful preparation of the desired aziridines 5b–5e was achieved by the cyclization 
reaction, using commercially available dichlorotriphenylphosphorane (Ph3PCl2) according to 
the procedure described in ref. [7a] (Scheme 2). A likely intermediate for the ring closure is the 
zwitterion 6. 
 
Scheme 2 
 
In the case of 5b, 5c, and 5e, the products were formed exclusively and were isolated as 
colorless oils in high yields (84–89%). Their structures were established on the basis of the 
spectroscopic data. In the low-resolution 
1
H-NMR spectra (80 MHz) of the N-isopropyl 
derivatives 5c and 5e, the aziridine CH2 group appears as a broad singlet at ca. 2.45 ppm and a 
quartet with JC,F = 3–4 Hz at higher field (ca. 2.05 ppm). The observed splitting of one of the 
signals results from a through-space coupling of the CF3 group with the cis-oriented H-atom. 
Surprisingly, no geminal coupling could be detected for the non-equivalent H-atoms at C(3). 
The N-(tert-butyl) derivatives 5b and 5d showed a similar signal pattern for the CH2 group, but, 
surprisingly, the difference of the chemical shifts in 5b was much smaller (∆ 1 ppmthan 
in the other cases (∆–0.46 ppm Moreover, the signal of the through-space coupled H-
atom of 5b appears at lower field, in contrast to the other examples.  
The reaction of 4c under the same conditions (refluxing MeCN) led to a mixture of 5d 
and a second product, in a ratio of ca. 1:1, which in the 
1
H-NMR spectrum showed, in addition 
                                                        
2
)  Thionyl chloride (SOCl2) was used as the chlorinating agent and Et3N as the base. The 
starting material was consumed, but only a complex a mixture of products was obtained [8]. 
 
6 
to a singlet for a tert-butyl group (1.10 ppm), an AB system at 3.30 and 3.60 ppm with JAB = 9.7 
Hz. In a small-scale experiment, carried out in refluxing toluene, the aziridine 5d was formed in 
traces only, and the second product was the major component of the reaction mixture. Diverse 
experiments, aimed at the optimization of the reaction conditions and the formation of 5d in 
higher yield, were unsuccessful. Chromatographic workup of the 1:1 mixture and distillation of 
the less polar fraction yielded pure 5d (42%). All attempts to isolate the new product in pure 
form were in vain, and the sample was always contaminated with 5d 
3)
. In an additional 
experiment, the isolated aziridine 5d was heated in boiling toluene for 12 h, but, after cooling, 
no 7d was found in the mixture (
1
H-NMR analysis). Thus, the by-product 7d was probably 
formed competitively from an intermediate appearing on the pathway to aziridine 5d. 
It is well known that -amino alcohols can be used for the synthesis of five-membered 
heterocycles via substitution or condensation reactions. Thus, the reaction of 4b with 
paraformaldehyde in boiling toluene yielded the trifluoromethyl-substituted 1,3-oxazolidine 8b 
in 62% yield (Scheme 3). On the other hand, the reaction of 4a, 4b, 4d, and 4f with phosgene in 
toluene at room temperature in the presence of Et3N led to the corresponding 1,3-oxazolidin-2-
ones 9 in excellent yields.  
 
Scheme 3 
 
                                                        
3
)  Based on the 
1
H-NMR data, the structure of the second product was tentatively assigned as 
2,2,5,5-tetrasubstituted piperazine derivative 7d. It is worth mentioning that only one isomer 
of 7d was formed in the described reaction. However, the configuration (cis or trans) of the 
substituents at C(2) and C(5) remains unknown. 
Formula 7d 
7 
Nucleophilic trifluoromethylation of the -imino ketone 2 with Ar = 4-MeOC6H4 and R 
= (S)-Ph(Me)CH led to the formation of the -amino alcohol 4g as a 6:4 mixture of 
diastereoisomers [3b]. Chromatographic separation on silica yielded the pure diastereoisomers 
(according to 
19
F-NMR), and the minor one (more polar fraction) was used for the reaction with 
phosgene. The corresponding 1,3-oxazolidin-2-one 9g was obtained as a single product, and the 
absolute configuration of the two stereogenic centers was unambiguously established by means 
of a single crystal X-ray diffraction analysis. 
 
Fig. 2. ORTEP-Plot [4] of the molecular structure of 9g (with 50% probability ellipsoids; 
arbitrary numbering of the atoms) 
 
The space group permits the compound in the crystal to be enantiomerically pure, but 
the absolute configuration of the molecule has not been determined. The enantiomer used in the 
refinement was based on the known S-configuration of the 1-phenylethyl substituent of the 
molecule. The compound thus has the 5R,1’S-configuration. 
In order to obtain a derivative of a 1,3,2-oxazaphospholidine, a solution of the -amino 
alcohol 4b in toluene was treated with dichloro(phenyl)phosphane in the presence of Et3N at 
60°. The product obtained thereby decomposed during typical workup and, therefore, the crude 
mixture was oxidized by addition of H2O2 at the same temperature. The oxidized product, i.e., 
the 1,3,2-oxazaphospholidine 2-oxide 10b was isolated and purified by layer chromatography 
in 68% yield as a 1:1 mixture of diastereoisomers (Scheme 3). The attempted synthesis of the 
corresponding 2-sulfide by sulfurization of the initially formed 1,3,2-oxazaphospholidine with 
elemental sulfur was achieved smoothly but the obtained product spontaneously extruded sulfur 
during the workup and decomposed to give an intractable mixture.  
8 
Finally, -amino alcohols 4b and 4e were reacted with SOCl2 in CH2Cl2 in the presence 
of Et3N at –45° yielding the desired 1,2,3-oxathiazolidine 2-oxides 11b and 11e, respectively, 
as mixtures of diastereoisomers in good yields (ca. 4:1 and 1:1 ratio, resp.). In analogy to 10b, 
the stereoisomers could not be separated by standard procedures.  
As an example for the formation of a six-membered heterocycle, -amino alcohols 4a 
and 4e were treated with oxalyl chloride in refluxing toluene. After crystallization from 
CH2Cl2/hexane and toluene, respectively, the morpholine-2,3-diones 12a and 12e were 
obtained as colorless crystals in 66 and 85% yield (Scheme 4). 
 
Scheme 4 
 
3. Conclusions. – The present study shows that the trifluoromethylated -amino 
alcohols 4, which can be prepared conveniently from monoimines of aryl glyoxals 2, are 
attractive building blocks for the synthesis of trifluoromethyl substituted three-, five-, and six-
membered heterocycles. The presence of the trifluoromethyl group, which is important for 
specific changes of physicochemical and biological properties of organic substances [9], 
enhances the attractiveness of the described approach. The examples of heterocycles selected in 
this paper can be further explored for the preparation of more complex structures.  
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Experimental Part 
1. General. M.p.: Melt-Temp. II (Aldrich), in capillary; uncorrected. IR Spectra: NEXUS 
FT-IR spectrophotometer; in KBr; absorptions in cm
–1
. 
1
H- and 
13
C-NMR Spectra: Bruker 
Avance III 600 instrument (600 and 150 MHz, resp.); in CDCl3; in ppmTMS = 0 ppm), 
coupling constants J in Hz. The 
13
C signals were assigned on the basis of HMQC experiments. 
19
F- and 
31
P-NMR Spectra: Varian Gemini BB 200 or Bruker Avance III 600 spectrometers; in 
CDCl3; with CCl3F or H3PO4, resp., as references. Some spectra were also run with Tesla BS 
spectrometer (80 MHz). HR-ESI-MS: Finnigan MAT-95.  
2. Starting Materials. The commercially available dichlorotriphenylphosphorane 
(Ph3PCl2), dichlorophenylphosphane (PhPCl2), oxalyl chloride ((COCl)2), paraformaldehyde 
((CH2O)n), and thionyl chloride (SOCl2) were purchased from Sigma-Aldrich and solution of 
phosgene in toluene (20%) from Fluka. β-Amino-α-trifluoromethyl alcohols (4) were prepared 
according to a previously described protocol [3b]. Toluene was dried over Na, MeCN and 
CH2Cl2 over CaH2, and they were freshly distilled prior to use. 
3. Syntheses of Trifluoromethylated Aziridines; Reactions with Ph3PCl2. – General 
Procedure. To the soln. of the appropriate β-amino alcohol 4 (1 mmol) and Ph3PCl2 (646 mg, 2 
mmol) in dry MeCN, Et3N (505 mg, 5 mmol) was added while cooling the mixture in an ice-
bath. Then, the mixture was heated to reflux for 10 h. The solvents were evaporated i.v. (for 5c 
and 5e, a water-bath at r.t. was used). The residue was washed with hexane, the precipitate 
filtered off, and the solvent evaporated. In the case of 5d, the mixture of products was separated 
by prep. layer chromatography on silica gel (PLC) with hexane/CH2Cl2 (1:1) as the mobile 
phase. 
1-(tert-Butyl)-2-phenyl-2-(trifluoromethyl)aziridine (5b). Yield: 205 mg (84%). 
Colorless oil, purified by distillation at 90º/0.1 Pa (Kugelrohr). IR (film): 3062m, 3042m, 
2976vs, 2934s, 2969vs, 2875m, 1604w, 1500m, 1474m, 1449m, 1364s, 1354s, 1334vs, 1217vs, 
10 
1173vs, 1147vs, 1114s, 1093m, 1052s, 1029m, 1010m, 826w. 
1
H-NMR (600 MHz): 7.58–7.57 
(m, 2 arom. H); 7.39–7.35 (m, 3 arom. H); 3.82 (s, MeO); 2.36 (br. q, 4JH,F = 1.2, 1 H of CH2); 
2.30 (br. s, 1 H of CH2); 0.88 (s, Me3C). 
13
C-NMR (150 MHz): 131.8 (1 arom. CH); 131.2 (1 
arom. C); 129.1, 128.4 (4 arom. CH); 124.8 (q, 
1
JC,F = 276.2, CF3); 54.5 (Me3C); 47.0 (q, 
2
JC,F 
= 34.7, Cq); 27.9 (Me3C); 27.3 (q, 
3
JC,F = 0.6, CH2). 
19
F-NMR (265 MHz): –76.4 (s, CF3). HR-
ESI-MS (MeOH + NaI): 266.11259 ([M + Na]
+
, C13H16F3NNa
+
; calc. 266.11271); 244.13067 
([M + 1]
+
, C13H17F3N
+
; calc. 244.13076). 
1-Isopropyl-2-phenyl-2-(trifluoromethyl)aziridine (5c). Yield: 188 mg (82%). Colorless 
oil, purified by distillation at ca. 30º/0.1 Pa (Kugelrohr). IR (film): 3062m, 3033m, 2973vs, 
2934s, 2873s, 1604w, 1581w, 1501s, 1463s, 1449s, 1369vs, 1356vs, 1444m, 1324s, 1281w, 
1203vs, 1174vs, 1139vs, 1051s, 1027s, 1011s, 896w, 855w. 
1
H-NMR (600 MHz): 7.54–7.53 
(m, 2 arom. H); 7.41–7.39 (m, 3 arom. H); 2.48 (br. s, 1 H of CH2); 2.05 (br. s, 1 H of CH2); 
1.62 (br. signal, Me2CH); 1.13 (d, 
3
JH,H = 6.0, 1 Me of Me2CH); 1.08 (d, 
3
JH,H = 4.2, 1 Me of 
Me2CH). 
1
H-NMR (80 MHz): 7.63–7.28 (m, 5 arom. H); 2.45 (br. s, 1 H of CH2); 2.05 (q, JH,F 
= 3.6, 1 H of CH2); 1.86–1.45 (br. m, Me2CH); 1.14 (d, 
3
JH,H = 6.0, 1 Me of Me2CH); 1.05 (d, 
3
JH,H = 4.2, 1 Me of Me2CH). 
13
C-NMR (150 MHz): 131.8 (1 arom. CH); 129.6 (1 arom. C); 
128.6 (4 arom. CH); 124.8 (q, 
1
JC,F = 276.2, CF3); 52.2 (Me2CH); 49.0 (q, 
2
JC,F = 34.7, Cq); 
33.1 (CH2); 22.6, 22.4 (Me2CH). 
19
F-NMR (565 MHz): –71.6 (s, CF3). HR-ESI-MS (MeCN + 
NaI): 230.11510 ([M + 1]
+
, C12H15F3N
+
; calc. 230.11511). 
1-(tert-Butyl)-2-(4-methoxyphenyl)-2-(trifluoromethyl)aziridine (5d) (less polar fracion). 
Yield: 110 mg (40%). Colorless semi-solid; distilled at 140º/0.1 Pa (Kugelrohr). IR (film): 
3046m, 2973vs, 2937vs, 2909s, 2841m, 1604vs, 1579m, 1518vs, 1466s, 1444m, 1391m, 1364s, 
1336vs, 1295vs, 1254vs, 1217vs, 1171vs, 1146vs, 1111s, 1052vs, 1035s, 1009m, 861m. 
1
H-
NMR (600 MHz): 7.35–7.39 (m, 3 arom. H); 7.47–7.48, 6.87–6.89 (2m, 2 arom. H); 3.82 (s, 
MeO); 2.69 (br. s, 1 H of CH2); 2.31 (q, 
4
JH,F = 0.6, 1 H of CH2); 0.88 (s, 9H, Me3C). 
13
C-NMR 
11 
(150 MHz): 124.9 (q, 
1
JC,F = 276.2, CF3); 160.1, 123.0 (2 arom. C); 139.2, 113.8 (4 arom. CH); 
55.2 (MeO); 54.4 (Me3C); 46.3 (q, 
2
JC,F = 34.7, Cq); 27.9 (Me3C); 27.4 (q, 
3
JC,F = 0.6, CH2). 
19
F-NMR (565 MHz): –71.6 (s, CF3). CI-MS (isobutane): 274 (100, [M+1]
+
). HR-ESI-MS 
(MeCN + NaI): 274.14131 ([M + 1]
+
, C14H19F3NO
+
; calc. 274.14133). 
1,4-Bis(tert-Butyl)-2,5-bis(4-methoxyphenyl)-2,5-bis(trifluoromethyl)-1,4-piperazine 
(7d) (more polar fraction, partially contaminated with 5d). Decomposes at r.t. Yield: 100 mg 
(36%). Pale yellow oil. 
1
H-NMR (80 MHz): 7.65–7.49, 7.00–6.81 (2m, 8 arom. H); 3.81 (s, 2 
MeO); 3.30, 3.60 (AB, JAB = 9.7, 2 CH2); 1.09 (s, 2 Me3C). 
1-Isopropyl-2-(4-methoxyphenyl)-2-(trifluoromethyl)aziridine (5e). Yield: 198 mg 
(84%). Colorless oil, distilled at 70º/0.1 Pa (Kugelrohr). IR (film): 3046m, 2973vs, 2937vs, 
2909s, 2841m, 1604vs, 1579m, 1518vs, 1466s, 1444m, 1391m, 1364s, 1336vs, 1295vs, 1254vs, 
1217vs, 1171vs, 1146vs, 1111s, 1052vs, 1035s, 109m, 861m. 
1
H-NMR (600 MHz): 7.46–7.45 
(m, 2 arom. H); 6.93–6.91 (m, 2 arom. H); 3.83 (s, MeO); 2.46 (br. s, 1 H of CH2); 2.00 (br. s, 1 
H of CH2); 1.62 (br. signal, Me2CH); 1.11, 1.08 (2d, 
3
JH,H = 6.0, Me2CH). 
1
H-NMR (80 MHz): 
7.53–7.36 (m, 2 arom. H); 6.99–6.80 (m, 2 arom. H); 3.81 (s, MeO); 2.42 (br. s, 1 H of CH2); 
1.99 (q, JH,F = 3.3, 1 H of CH2); 1.85-1.42 (br. m, 1H, Me2CH); 1.12, 1.05 (2d, 
3
JH,H = 6.0, 
Me2CH). 
13
C-NMR (150 MHz): 160.4, 127.6 (2 arom. C); 133.0, 113.9 (4 arom. CH); 124.8 (q, 
1
JC,F = 273.0, CF3); 55.3 (MeO); 52.2 (Me2CH); 48.3 (q, 
2
JC,F = 35.0, Cq); 33.2 (CH2); 22.5, 
22.4 (Me2CH). 
19
F-NMR (56.5 MHz): –71.9 (s, CF3). HR-ESI-MS (MeOH + NaI): 260.12581 
([M + 1]
+
, C13H17F3NO
+
; calc. 260.12568). 
4. Synthesis of Five-Membered Heterocycles. 4.1. Reaction with (CH2O)n. In a round 
bottom falsk with a Dean-Stark trap, a mixture of 4a (261 mg, 1 mmol) and paraformaldehyde 
(45 mg, 1.5 mmol) in toluene (ca. 10ml) was heated to reflux for 12 h. Then, the solvent was 
evaporated and the crude product was purified by filtration trough a pad of neutral Al2O3 
(eluent: hexane/CH2Cl2 9:1). 
12 
3-(tert-Butyl)-5-phenyl-5-(trifluoromethyl)-1,3-oxazolidine (8b). Yield: 169 mg (62%). 
Colorless, viscous oil. IR (film): 3063w, 2972m, 2939m, 2876w, 1643w, 1496w, 1450w, 
1389w, 1367m, 1307m, 1258m, 1176vs, 1164vs, 1086s, 1062m, 1030m, 1019m, 992w, 920w, 
859w. 
1
H-NMR (600 MHz): 7.43–7.42 (m, 2 arom. H); 7.30–7.25 (m, 3 arom. H); 4.63, 4.59 
(2d, 
2
JH,H = 10.2, CH2); 3.52, 3.31 (2d, 
2
JH,H = 10.2, CH2); 0.95 (s, Me3C). 
13
C-NMR (150 
MHz): 137.7 (1 arom. C); 128.7, 128.5, 126.8 (5 arom. CH); 125.5 (q, 
1
JC,F = 285.3, CF3); 84.2 
(q, 
2
JC,F = 28.7, Cq); 83.1, 53.3 (2 CH2); 52.6 (Me3C); 25.7 (Me3C). 
19
F-NMR (188 MHz): –
77.03 (s, CF3). HR-ESI-MS (MeOH + NaI): 296.12297 ([M + Na]
+
, C14H18F3NNaO
+
; calc. 
296.12327); 274.14134 ([M + 1]
+
, C14H19F3NO
+
; calc. 274.14133).  
4.2. Cyclization with COCl2. – General Procedure. To the soln. of an appropriate amino 
alcohol 4 (1 mmol) in dry toluene (2 ml), Et3N (253 mg, 2.5 mmol) was added; an 
enantiomerically pure diastereoisomer 4g [3b] was used for preparation of 9g. Then, a soln. of 
phosgene was added drop-wise while cooling the mixture in an ice bath, and the mixture was 
magnetically stirred overnight. Next day, the solvent was evaporated and crude products were 
purified by filtration trough a plug of neutral Al2O3 using a mixture of hexane and CH2Cl2 (7:3) 
as an eluent. 
3-(tert-Butyl)-5-(4-nitrophenyl)-5-(trifluoromethyl)-1,3-oxazolidin-2-one (9a). Yield: 
316 mg (95%). Colorless crystals, m.p. 154–156º (petroleum ether/CH2Cl2). IR (KBr): 3116w, 
3078w, 2983m, 2939w, 1767vs (C=O), 1608m, 1522vs, 1478m, 1416m, 1352vs, 1459w, 1310s, 
1295vs, 1272s, 1238s, 1212s, 1192vs, 1177vs, 1141m, 1073s, 1041m, 1001s, 861m, 849s. 
1
H-
NMR (600 MHz): 8.32–8.30, 7.73–7.71 (2m, 4 arom. CH); 4.28, 3.86 (2d, 2JH,H = 9.6, CH2); 
1.42 (s, Me3C). 
13
C-NMR (150 MHz): 153.3 (CO); 149.0, 141.4 (2 arom. C); 127.6, 124.5 (4 
arom. CH); 123.5 (q, 
1
JC,F = 285.3, CF3); 77.5 (q, 
2
JC,F = 31.7, Cq); 54.9 (Me3C); 50.5 (CH2); 
27.5 (Me3C). 
19
F-NMR (565 MHz): –81.0 (s, CF3). ESI-MS (MeOH): 355 (100, [M+Na]
+
). HR-
13 
ESI-MS (MeOH + NaI): 355.08775 ([M + Na]
+
, C14H15F3N2NaO4
+
; calc. 355.08761); 
333.10557 ([M + 1]
+
, C14H16F3N2O4
+
; calc. 333.10567). 
3-(tert-Butyl)-5-phenyl-5-(trifluoromethyl)-1,3-oxazolidin-2-one (9b). Yield: 275 mg 
(96%). Colorless crystals, m.p. 53–55º (petroleum ether). IR (KBr): 2980w, 2913w, 1767vs 
(C=O), 1635w, 1452w, 1412w, 1370w, 1291w, 1238m, 1171s, 1050w, 1035w, 1011w, 758w. 
1
H-NMR (600 MHz): 7.51–7.49 (m, 2 arom. H); 7.45–7.43 (m, 3 arom. H); 4.23, 3.88 (2d, 2JH,H 
= 9.3, CH2); 1.41 (s, Me3C). 
13
C-NMR (150 MHz): 153.8 (CO); 134.6 (1 arom. C); 129.7, 
128.7, 125.9 (5 arom. CH); 123.8 (q, 
1
JC,F = 283.7, CF3); 77.6 (q, 
2
JC,F = 30.9, Cq); 54.3 
(Me3C); 50.5 (CH2); 27.3 (Me3C). 
19
F-NMR (188 MHz): –80.5 (s, CF3). ESI-MS (MeOH): 310 
(100, [M+Na]
+
). HR-ESI-MS (MeOH + NaI): 310.10266 ([M + Na]
+
, C14H16F3NNaO2
+
; calc. 
310.10253); 288.12028 ([M + 1]
+
, C14H17F3NO2
+
; calc. 288.12059). 
3-(tert-Butyl)-5-(4-methoxyphenyl)-5-(trifluoromethyl)-1,3-oxazolidin-2-one (9d). 
Yield: 310 mg (97%). Colorless crystals, m.p. 107–109º (petroleum ether/CH2Cl2). IR (KBr): 
2982w, 2942w, 1763vs (C=O), 1611m, 1518s, 1459w, 1411m, 1294s, 1252vs, 1205s, 1171vs, 
1073m, 1023s, 1011m, 844w. 
1
H-NMR (600 MHz): 7.42–7.40, 6.96–6.93 (2m, 4 arom. H); 4.19 
(d, 
2
JH,H = 9.6, 1 H of CH2); 3.84 (dq, 
2
JH,H = 9.6, 
4
JH,F = 0.6, 1 H of CH2); 3.82 (s, MeO); 1.40 
(s, Me3C). 
13
C-NMR (150 MHz): 160.5 (CO); 153.9, 126.6 (2 arom. C); 127.3, 114.1 (4 arom. 
CH); 123.8 (q, 
1
JC,F = 283.5, CF3); 77.5 (q, 
2
JC,F = 30.2, Cq); 55.3 (MeO); 54.2 (Me3C); 50.5 
(CH2); 27.3 (Me3C). 
19
F-NMR (188 MHz): –80.8 (s, CF3). ESI-MS (MeOH): 340 (100, 
[M+23]
+
), 318 (45, [M+1]
+
). HR-ESI-MS (MeOH + NaI): 340.11330 ([M + Na]
+
, 
C15H18F3NNaO3
+
; calc. 340.11310); 318.113083 ([M + 1]
+
, C15H19F3NO3
+
; calc. 318.13115). 
3-(tert-Butyl)-5-(trifluoromethyl)-5-[4-(trifluoromethyl)phenyl]-1,3-oxazolidin-2-one 
(9f). Yield: 246 mg (92%). Colorless crystals, m.p. 117–119º (hexane/CH2Cl2). IR (KBr): 
2989w, 2920w, 1766vs (C=O), 1622w, 1417m, 1371w, 1332s, 1291w, 1181s, 1135m, 1107m, 
1072m, 1018m, 852w. 
1
H-NMR (600 MHz): 7.73–7.71, 7.66–7.64 (2m, 4 arom. H); 4.26, 3.85 
14 
(2d, 
2
JH,H = 9.6, CH2); 1.41 (s, Me3C). 
13
C-NMR (150 MHz): 153.6 (CO); 138.7 (1 arom. C); 
132.3 (q, 
2
JC,F = 33.2, 1 arom. C); 126.8 (2 arom. CH), 126.1 (q, 
3
JC,F = 3.0, 2 arom. CH); 123.8 
(q, 
1
JC,F = 271.7, CF3); 123.7 (q, 
1
JC,F = 285.3, CF3); 77.6 (q, 
2
JC,F = 31.7, Cq); 54.7 (Me3C); 
50.6 (CH2); 27.5 (Me3C). 
19
F-NMR (565 MHz): –60.0 (s, CF3); –81.3 (s, CF3). ESI-MS: 378 
(100, [M+Na]
+
). HR-ESI-MS (MeOH + NaI): 378.08994 ([M + Na]
+
, C15H15F6NNaO2
+
; calc. 
378.08992); 356.10780 ([M + 1]
+
, C15H16F6NO2
+
; calc. 356.10797). 
(5R,1’S)-5-(4-Methoxyphenyl)-3-(1-phenylethyl)-5-(trifluoromethyl)-1,3-oxazolidin-2-
one (9g). Yield: 332 mg (91%). Colorless crystals, mp. 120–122º (hexane/CH2Cl2). [a]D
20
 = + 
31 (c 1; CH2Cl2). IR (KBr): 3066w, 3030w, 1755vs (C=O), 1612w, 1517m, 1439w, 1281m, 
1254s, 1213w, 1182vs, 1034s, 1024s, 832w. 
1
H-NMR (600 MHz): 7.43–7.39 (m, 4 arom. H); 
7.36–7.34 (m, 3 arom. H); 6.96–6.95 (m, 2 arom. H); 5.27 (q, 3JH,H = 7.2, CH); 3.84 (s, MeO); 
3.72, 3.70 (2d, 
2
JH,H = 9.5, CH2); 1.55 (d, 
2
JH,H = 7.2, Me). 
13
C-NMR (150MHz): 160.9 (C=O); 
155.2, 138.7, 126.4 (3 arom. C); 123.8 (q, 
1
JC,F = 283.7, CF3); 128.5, 127.6, 127.1, 126.6, 114.4 
(9 arom. CH); 79.2 (q, 
3
JC,F = 31.7, Cq); 52.0 (CH2); 48.0 (CH); 16.2 (Me). 
19
F-NMR (565 
MHz): –81.8 (s, CF3). HR-ESI-MS (MeOH + NaI): 388.11329 ([M + Na]
+
, C19H18F3NNaO3
+
; 
calc. 388.11310). 
Suitable crystals for a crystal-structure determination were obtained from 
hexane/CH2Cl2 by slow evaporation of the solvent. 
4.3. Cyclization with PhPCl2. To the soln. of 4a (261mg, 1 mmol) in dry toluene (Ar 
atmosphere), a soln. of PhPCl2 (286 mg, 1.6 mmol) in toluene was added dropwise while 
cooling the round-bottom flask in an ice-bath. Then, Et3N (354mg, 3.5 mmol) was added and 
the mixture was heated for 3.5 h. The precipitate (Et3N
.
HCl) was filtered off, a 30% soln. of 
H2O2 (400 mg, 3.5 mmol) was added to the filtrate, and the mixture was heated in 60º for 3 h. 
The org. phases were diluted with H2O and extracted with CH2Cl2. Org. layers were combined, 
15 
dried (Na2SO4) and solvents evaporated. The product was isolated as a mixture of two 
diastereoisomers, PLC on silica gel with CH2Cl2/hexane (1:1) as the eluent.  
3-(tert-Butyl)-5-phenyl-5-(trifluoromethyl)-1,3,2-oxazaphospholidine 2-Oxide (10b). 
Yield: 260 mg (68%). Yellow oil. IR (film): 3062w, 2976m, 2940w, 2889w, 1683w, 1592w, 
1485w, 1450m, 1440m, 1399w, 1369w, 1310s, 1270vs, 1244vs, 1226vs, 1174vs, 1140s, 1119s, 
1071s, 1043s, 1014s, 923w, 861s. 
1
H-NMR (600 MHz): major isomer: 7.97–7.93, 7.71–7.73 
7.58–7.54, 7.50–7.39, 7.33–7.32 (5m, 10 arom. H); 4.17 (dd, 2JH,H = 9.6, 
3
JH,P = 7.8, 1 H of 
CH2); 4.00 (dd, 
2
JH,H = 9.6, 
3
JH,P = 9.6, 1 H of CH2); 1.18 (s, Me3C); minor isomer: 7.97–7.93, 
7.71–7.73 7.58–7.54, 7.50–7.39, 7.33–7.32 (5m, 10 arom. H); 4.32 (dd, 2JH,H = 10.2, 
3
JH,P = 7.8, 
1 H of CH2); 3.90 (dd, 
2
JH,H = 10.2, 
3
JH,P = 10.2, 1 H of CH2); 1.28 (s, Me3C). 
13
C-NMR (150 
MHz): major isomer: 123.9 (qd, 
1
JC,F = 283.8, 
3
JC,P = 9.1, CF3); 113.90 (2 arom. CH); 81.3 (q, 
2
JC,F = 31.7, Cq); 53.2 (d, 
2
JC,P = 4.5, Me3C); 51.5 (d, 
2
JC,P = 9.1, CH2); 28.4 (d, 
3
JC,P = 3.0, 
Me3C); minor isomer: 123.7 (q, 
1
JC,F = 285.3, 
3
JC,P = 3.6, CF3); 80.9 (q, 
2
JC,F = 31.7, Cq); 50.9 
(d, 
2
JC,P = 10.6, CH2); 53.3 (d, 
2
JC,P = 4.5, Me3C); 50.9 (d, 
2
JC,P = 10.6, CH2); 28.5 (d, 
3
JC,P = 
3.0, Me3C); complex signals attributed to aromatic C-atoms of both diastereoisomers were 
found between 126.2 and 135.3 ppm. 
19
F-NMR (188 MHz): major isomer: –78.46 (s, CF3); 
minor isomer: –79.31 (s, CF3). HR-ESI-MS (MeOH + NaI): 406.11509 ([M + Na]
+
, 
C19H21F3NNaO2P
+
; calc. 406.11542); 384.13295 ([M + 1]
+
, C19H22F3NO2P
+
; calc. 384.13347). 
4.4. Reactions with SOCl2. – General procedure. To the soln. of an amino alcohol 4 (1 
mmol) and Et3N (253 mg, 2.5 mmol) in dry CH2Cl2, SOCl2 (92 mg, 1.1 mmol) was added drop-
wise (Ar atmosphere), while cooling the mixture in an acetone/dry ice bath (ca. −45º. The 
mixture was stirred for 3 h, diluted with H2O, and extracted with CH2Cl2. The org. layers were 
combined, dried (anh. Na2SO4), filtered, and the solvent was evaporated. Products were 
obtained as a mixture of diastereoisomers and, without separation, were purified by filtration 
through silica gel pad using hexane/CH2Cl2 (1:1) as the eluent. 
16 
3-(tert-Butyl)-5-phenyl-5-(trifluoromethyl)-1,2,3-oxathiazolidine 2-Oxide (11b). Yield: 
260–280 mg (85–91%, mixture of two diastereoisomers). Yellow oil. The ratio of the 
diastereoisomers (ca. 1:4) was determined for a freshly prepared sample, and no change of this 
ratio was observed during the storage.  IR (film): 3063w, 2976s, 2935m, 1738w, 1603w, 
1496m, 1450m, 1399w, 1372m, 1300s, 1269s, 1204vs, 1174vs, 1113m, 1074m, 1008s, 959s, 
876w. 
1
H-NMR (600 MHz): major isomer: 7.54–7.52 (m, 2 arom. H); 7.43–7.40 (m, 3 arom. 
H); 4.27 (d, 
2
JH,H = 9.6, 1 H of CH2); 3.87 (dq, 
2
JH,H = 9.6, 
4
JH,F = 0.6, 1 H of CH2); 1.30 (s, 
Me3C); minor isomer: 7.54–7.52 (m, 2 arom. H); 7.43–7.40 (m, 3 arom. H); 4.18 (d, 
2
JH,H = 
10.2, 1 H of CH2); 3.98 (dq, 
2
JH,H = 10.2, 
4
JH,F = 1.2, 1 H of CH2); 1.41 (s, Me3C). 
13
C-NMR 
(150 MHz): major isomer: 134.7 (1 arom. C); 129.4, 128.4, 125.9 (5 arom. CH); 123.1 (q, 
1
JC,F 
= 282.3, CF3); 89.8 (q, 
2
JC,F = 30.8, Cq); 54.9 (Me3C); 48.8 (CH2); 28.4 (Me3C); minor isomer: 
135.7 (1 arom. C); 129.3, 128.5, 126.3 (5 arom. CH); 123.7 (q, 
1
JC,F = 285.3, CF3); 90.1 (q, 
2
JC,F = 29.7, Cq); 54.8 (Me3C); 49.5 (CH2); 29.6 (Me3C). 
19
F-NMR (188 MHz): major isomer: –
75.2 (s, CF3); minor isomer: –78.8 (s, CF3). HR-ESI-MS (MeOH + NaI): 330.07490 ([M + 
Na]
+
, C13H16F3NNaO2S
+
; calc. 330.07461). 
3-Isopropyl-5-(4-methoxyphenyl)-5-(trifluoromethyl)-1,2,3-oxathiazolidine 2-Oxide 
(11e). Yield: 220 mg (71%). Yellow oil. Mixture of diastereoisomers; a ratio of ca. 15:85 was 
determined for a freshly prepared sample. After several weeks storage in the refrigerator, a ca. 
1:1 mixture of both isomers was formed. IR (film): 3018w, 2972m, 2939m, 2845w, 1612s, 
1518vs, 1467m, 1377w, 1297s, 1260vs, 1207s, 1173vs, 1145vs, 1092s, 1031s, 996s, 884w, 
834s. 
1
H-NMR (600 MHz): major isomer: 7.45–7.42 (m, 2 arom. H); 6.95–6.90 (m, 2 arom. H); 
4.12, 3.83 (2d, 
2
JH,H = 9.6, CH2); 3.81 (s, MeO); 3.47 (sept, 
3
JH,H = 6.6, Me2CH); 1.24, 1.23 
(2d, 
3
JH,H = 6.6, Me2CH); minor isomer: 7.45–7.42 (m, 2 arom. H); 6.95–6.90 (m, 2 arom. H); 
3.84, 4.13 (2d, 
2
JH,H = 9.6, CH2); 3.82 (s, MeO); 3.49 (sept, 
3
JH,H = 6.0, Me2CH); 1.38, 1.30 
(2d, 
3
JH,H = 6.0, Me2CH). 
13
C-NMR (150 MHz): major isomer: 160.4 (1 arom. C); 127.3 (2 
17 
arom. CH); 126.6 (1 arom. C); 123.12 (q, 
1
JC,F = 283.8, CF3); 113.90 (2 arom. CH); 90.2 (q, 
2
JC,F = 31.7, Cq); 55.3 (MeO); 51.8 (CH2); 47.2 (Me2CH); 21.6, 21.5 (Me2CH); minor isomer: 
160.3 (1 arom. C); 127.6 (2 arom. CH); 126.6 (1 arom. C); 123.7 (q, 
1
JC,F = 285.3, CF3); 113.86 
(2 arom. CH); 90.5 (q, 
2
JC,F = 30.2, Cq); 55.3 (MeO); 51.0 (CH2); 47.23 (Me2CH); 21.7, 21.4 
(Me2CH). 
19
F-NMR (188 MHz): major isomer: –79.1 (s, CF3); minor isomer: –75.7 (s, CF3). 
HR-ESI-MS (MeOH + NaI): 346.06928 ([M + Na]
+
, C13H16F3NNaO3S
+
; calc. 346.06952). 
5. Syntheses of Six-membered Heterocycles. Reaction with Oxayl Chloride. – General 
Procedure. To a soln. of amino alcohol 4 (1 mmol) in dry toluene (5 ml), oxalyl chloride (207 
mg, 1.3 mmol) was added drop-wise. The mixture was refluxed for 4 h. Then, toluene was 
evaporated and the crude product was crystallized from an appropriate solvent. 
4-(tert-Butyl)-6-(4-nitrophenyl)-6-(trifluoromethyl)morpholine-2,3-dione (12a). Yield: 
306 mg (85%). Colorless crystals, m.p. 143–144º (toluene). IR (KBr): 3120w, 3092w, 2979w, 
2938w, 1792vs (C=O), 1693vs (C=O), 1610w, 1530vs, 1423w, 1355vs, 1293m, 1192vs, 1147vs, 
1127s, 1059w, 944m, 855m. 
1
H-NMR (200 MHz): 8.37–8.35, 7.75–7.74 (2m, 4 arom. H); 4.32, 
4.22 (2d, 
2
JH,H = 14.4, CH2); 1.39 (s, Me3C). 
13
C-NMR (150 MHz): 154.3, 152.6 (2 CO); 149.3, 
138.3 (2 arom. C); 127.8, 124.6 (4 arom. CH); 122.4 (q, 
1
JC,F = 286.8, CF3); 81.4 (q, 
2
JC,F = 
30.2, Cq); 59.8 (Me3C); 45.2 (CH2); 19.0 (Me3C). 
19
F-NMR (565 MHz): –75.7 (s, CF3). HR-
ESI-MS (MeCN + NaI): 383.08240 ([M + Na]
+
, C15H15F3N2NaO5
+
; calc. 383.08253). 
4-Isopropyl-6-(4-methoxyphenyl)-6-(trifluoromethyl)morpholine-2,3-dione (12e). Yield: 
210mg, (66%). Colorless crystals, m.p. 148–150º (CH2Cl2/hexane). IR (KBr): 3026w, 2291w, 
2978w, 2848w, 1776vs (C=O), 1689vs (C=O), 1609m, 1517s, 1481m, 1443m, 1342m, 1308m, 
1263vs, 1180vs, 1160vs, 1137s, 1112m, 1028m, 991m, 835m. 
1
H-NMR (600 MHz): 7.40–7.38, 
6.96–6.94 (2m, 4 arom. H); 4.75–4.65 (m, Me2CH); 4.12, 3.94 (2d, 
2
JH,H = 14.1, CH2); 3.83 (s, 
MeO); 1.21 (2d, 
3
JH,H = 6.9, Me2CH). 
13
C-NMR (150 MHz): 161.1, 154.4 (2 CO); 151.8, 122.7 
(2 arom. C); 122.6 (q, 
1
JC,F = 285.3, CF3); 114.7, 127.6 (4 arom. CH); 81.4 (q, 
2
JC,F = 31.7, Cq); 
18 
55.42 (MeO); 46.1 (Me2CH); 42.2 (CH2); 19.0 (Me2CH). 
19
F-NMR (188 MHz): –76.7 (s, CF3). 
HR-ESI-MS (MeCN + NaI): 354.09216 ([M + Na]
+
, C15H16F3NNaO4
+
; calc. 354.09236). 
6. X-Ray Crystal-Structure Determination of 4a and 9g (Table and Fig. 1 and 2)
4
). All 
measurements were performed on a Nonius KappaCCD diffractometer 10 using graphite-
monochromated MoK radiation ( 0.71073 Å) and an Oxford Cryosystems Cryostream 700 
cooler. The data collection and refinement parameters are given in the Table, and views of the 
molecules are shown in Fig.1 and 2. Data reduction was performed with HKL Denzo and 
Scalepack 11. The intensities were corrected for Lorentz and polarization effects but not for 
absorption. Equivalent reflections were merged. The structures were solved by direct methods 
using SHELXS97 12, which revealed the positions of all non-H-atoms. The non-H-atoms 
were refined anisotropically. The amine and hydroxy H-atoms of 4a were placed in the 
positions indicated by a difference electron density map and their positions were allowed to 
refine with individual isotropic displacement parameters, while the O–H and N–H distances 
were restrained to suitable values. All remaining H-atoms and all H-atoms of 9g were placed in 
geometrically calculated positions and refined using a riding model where each H-atom was 
assigned a fixed isotropic displacement parameter with a value equal to 1.2Ueq of its parent C-
atom (1.5Ueq for the Me groups). The refinement of each structure was carried out on F
2
 using 
full-matrix least-squares procedures, which minimized the function w(Fo
2
 – Fc
2
)
2
. In both 
cases, one reflection, whose intensity was considered to be an extreme outlier, was omitted 
from the final refinement. Neutral atom scattering factors for non-H-atoms were taken from 
13a, and the scattering factors for H-atoms were taken from 14. Anomalous dispersion 
                                                        
4
) CCDC-779928 and 779929 contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from the Cambridge Crystallographic Data Centre, 
via www.ccdc.cam.ac.uk/data_request/cif. 
19 
effects were included in Fc 15; the values for f' and f" were those of 13b. The values of the 
mass attenuation coefficients are those of 13c. All calculations were performed using the 
SHELXL97 32 program. 
 
Table.  Crystallographic Data for Compounds 4a and 9g 
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Legends 
 
Fig. 1. ORTEP-Plot [4] of the molecular structure of 4a (with 50% probability ellipsoids; 
arbitrary numbering of the atoms) 
 
Fig. 2. ORTEP-Plot [4] of the molecular structure of 9g (with 50% probability ellipsoids; 
arbitrary numbering of the atoms) 
 
 
Table.  Crystallographic Data for Compound 4a and 9g 
__________________________________________________________________________________ 
 
 4a 9g 
__________________________________________________________________________________ 
 
Crystallized from hexane/Et2O hexane/CH2Cl2 
Empirical formula C13H17F3N2O3 C19H18F3NO3 
Formula weight 306.28 365.35 
Crystal color, habit colorless, tablet colorless, prism 
Crystal dimensions [mm] 0.08  0.15  0.15 0.25  0.28  0.35 
Temperature [K] 160(1) 160(1) 
Crystal system triclinic monoclinic 
Space group P
_
,1 P21 
Z 2 2 
Reflections for cell determination 2649 2045 
2range for cell determination [°] 4–50 4–55 
Unit cell parameters a [Å] 6.8276(3) 6.4391(2) 
 b [Å] 9.3896(4) 14.7662(4) 
 c [Å] 12.7135(5) 9.0768(2) 
  [°] 73.634(2) 90 
  [°] 76.284(2) 93.755(2) 
  [°] 89.260(2) 90 
 V [Å3] 758.45(6) 861.18(4) 
23 
Dx [g cm
–3
] 1.341 1.409 
(MoK) [mm
–1
] 0.119  0.116 
Scan type    and  
2(max) [°] 50 55 
Total reflections measured 14693 20611 
Symmetry independent reflections 2674 2049 
Reflections with I > 2(I) 1927 1930 
Reflections used in refinement 2673 2048 
Parameters refined; restraints 201; 2 238; 1 
Final R(F)  [I > 2 (I) reflections] 0.0685  0.0309 
 wR(F
2
)  (all data) 0.2083  0.0797 
Weighting parameters [a; b]
a
) 0.1037; 0.7456 0.0481; 0.0874 
Goodness of fit 1.031 1.075 
Secondary extinction coefficient - 0.044(6) 
Final max/ 0.001 0.001 
 (max; min) [e Å
–3
] 0.59; –0.32 0.17; –0.17 
 
a) w–1 =  2(Fo2) + (aP)2 + bP  where P = (Fo2 + 2Fc2)/3 
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Scheme 2 
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Scheme 4 
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Formula 7d 
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Figure 1 
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Figure 2 
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